Clinical Trial Update: Docetaxel, Gemcitabine and Pazopanib as Treatment for Soft Tissue Sarcoma [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluated a combination of docetaxel, gemcitabine, and pazopanib for soft tissue sarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Gemcitabine (Gemcitabine)
• Pazopanib (Pazopanib)

Snippet

Sponsor: University of Vermont | Conditions: Stage III Adult Soft Tissue Sarcoma | Phase 1, Phase 2 | Status: COMPLETED